Evidence map›Paper›PMID 40510161›Full record

ArticleFrontiers in oncology2025

Development of CSOARG: a single-cell and multi-omics-based machine learning model for ovarian cancer prognosis and drug response prediction.

Junyu Chen, Bin Guan, Jihong Zhang, Xin Li, Jingyi Fang, Wencai Guan, Qi Lu, Guoxiong Xu

Abstract read
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Junyu ChenResearch Center for Clinical Medicine, Jinshan Hospital, Fudan University, Shanghai, China.
Bin GuanResearch Center for Clinical Medicine, Jinshan Hospital, Fudan University, Shanghai, China.
Jihong ZhangResearch Center for Clinical Medicine, Jinshan Hospital, Fudan University, Shanghai, China.
Xin LiResearch Center for Clinical Medicine, Jinshan Hospital, Fudan University, Shanghai, China.
Jingyi FangResearch Center for Clinical Medicine, Jinshan Hospital, Fudan University, Shanghai, China.
Wencai GuanResearch Center for Clinical Medicine, Jinshan Hospital, Fudan University, Shanghai, China.
Qi LuResearch Center for Clinical Medicine, Jinshan Hospital, Fudan University, Shanghai, China.
Guoxiong XuResearch Center for Clinical Medicine, Jinshan Hospital, Fudan University, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Ovarian cancer is the most deadly gynaecological malignancy. This study aims to generate a predictive model for prognosis and therapeutic responses in ovarian cancer using defined specific genes. Methods: The cellular senescence-associated gene sets and the ovarian aging-associated gene sets from the TCGA and GEO databases were analyzed using Cox regression with LASSO approach and employed to construct a prognostic model of Cellular Senescence and Ovarian Aging-Related Genes (CSOARG). Immunology analysis, functional enrichment, single-cell analysis, and therapeutic responses of ovarian cancer were conducted using the data from public databases. A machine learning model based on the expression levels of prognostic genes combined with clinical features was developed to predict the five-year overall survival. Patients with high- and low-risk scores were separated by the median risk score. Defined genes were verified by qRT-PCR and Western blot. The cellular behavior was evaluated by CCK-8, migration, and wound-healing assays. Results: After a series of calculations, an 8-gene CSOARG model was generated. CSOARG was correlated with genomic instability that harbored homologous recombination deficiency. The area under the curve (AUC) for 5-year overall survival was 0.68. Patients in the high-risk score group had a higher IC Conclusions: These findings demonstrate that a novel CSOARG model can effectively predict the prognosis and therapeutical responses of patients with ovarian cancer, which may assist clinicians in implementing better practices.

Indexed as

drug sensitivitygene signatureimmunotherapyovarian tumorprognosissenescence

Identifiers

PMID40510161
PMCPMC12159008

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.